TCMD | tickerfilter.com

Fundamental analysis

27%

Profitability 42%

Dept financing 17%

Liquidity 42%

Performance 10%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

1.94%

1 Month

-8.40%

3 Months

24.68%

6 Months

53.09%

1 Year

20.77%

2 Year

47.87%

Key data

Stock price

$17.30

P/E Ratio

9.98

DAY RANGE

$13.80 - $16.90

EPS

$1.36

52 WEEK RANGE

$11.38 - $21.10

52 WEEK CHANGE

$18.21

MARKET CAP

325.304 M

YIELD

N/A

SHARES OUTSTANDING

23.762 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/04/2024

BETA

1.13

PUBLIC FLOAT

AVERAGE 10 VOLUME

$263,779

AVERAGE 30 VOLUME

$344,167

Company detail

CEO: Daniel L. Reuvers
Region: US
Website: tactilemedical.com
Employees: 980
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Tactile Systems Technology, Inc. engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, venous insufficiency, and venous leg ulcers. AffloVest is a portable high frequency chest wall oscillation test for the. treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis.

TCMD - TACTILE SYSTEMS TECHNOLOGY INC